Taiwan Cell Manufacturing Company Ltd.

Update：2025/12/24

Industries

Biotechnology Biopharma Genetics

Add to Favorites Edit

About

Financials

Patent

News

Main Industry

Biotechnology

Founded Year

2021

Unified Business No.

91062335

Status

Active

Number of Employees

Total Paid-in Capital

505,000,000 (NT$)

Location of Company

Taiwan , Hsinchu County

Website

Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, Ministry of Economic Affairs.

Exclusive content for members

Members-only content. Please log in to access.

Similar Companies

Taiwan Bio-Manufacturing Corporation

TBMC will leverage existing resources to integrate intelligent and smart platform to establish various biopharmaceuticals manufacturing facility.

Biotechnology Biopharma Genetics Manufacturing Pharmaceutical

Rephlmmune Biotechnology Inc.

RephImmune is pioneering a new frontier in cancer immunotherapy with its proprietary platform, Reconstitute-Immunity Antigen-Cell Engager (RACE). This cutting-edge technology is rooted in regeneration biology and is specifically designed to reprogram and

Biotechnology Biopharma Genetics Oncology Therapeutics

ARCE THERAPEUTICS, INC.

ARD103
ANTI-CLL1 auto-CAR-T
ARD103, our priority product, is an autologous CAR-T cell manufactured by DashCAR® technology with an ultra-fast processing time and stem cell-like phenotypes. ARD103 specifically targeted C-type lectin-like molecule-1 (CLL-1)

Biotechnology Biopharma Genetics Oncology Therapeutics

Rock BioMedical, Inc.

Rock Bio’s Low-Sugar Universal Vaccine™ technology stems from pioneering glycoengineering research led by Professor Chi-Huey Wong and was recognized by IUPAC in 2023 as one of the Top 10 Emerging Technologies in Chemistry. This approach addresses viral im

Biotechnology Biopharma Genetics